Cognitive Training + tDCS for Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a gentle brain stimulation technique, transcranial direct current stimulation (tDCS), can enhance the effects of brain exercises on depression in older adults. It targets individuals who have experienced depression at least twice, with one episode occurring in the last three years. Participants may receive either real or sham brain stimulation during cognitive training sessions. This trial suits those over 60 who have had depression and face memory or thinking challenges in daily life. As an unphased trial, it provides an opportunity to contribute to innovative research that could improve depression treatments for older adults.
Will I have to stop taking my current medications?
The trial requires that participants either have a stable antidepressant regimen for at least 6 weeks or not be on any current antidepressant treatment. However, you cannot participate if you are taking medications that significantly interact with tDCS, like sodium channel blockers or anticonvulsants.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that transcranial direct current stimulation (tDCS) combined with cognitive training is safe for individuals with various mental health conditions. Studies have found that this combination enhances thinking skills and is generally well-tolerated.
For example, one study found that a 10-week tDCS treatment for major depression was both effective and safe, with participants reporting high satisfaction. Another study demonstrated that this method did not cause any major side effects and remained safe even when conducted remotely.
Overall, existing research suggests that tDCS with cognitive training is safe for individuals.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for depression because they combine cognitive training with transcranial direct current stimulation (tDCS), offering a potentially new way to enhance brain function. Unlike traditional antidepressants, which often target chemical imbalances, this approach may help in rewiring brain networks through non-invasive electrical stimulation. The study features two arms: one uses active tDCS, which could directly influence brain activity, and the other uses sham stimulation to help determine the effectiveness of the active approach. This combination could offer a novel, non-pharmaceutical option for those who haven't responded well to existing therapies.
What evidence suggests that this trial's treatments could be effective for depression?
In this trial, participants will be divided into two groups. One group will receive Cognitive Training combined with active transcranial direct current stimulation (tDCS). A previous study showed that combining brain exercises with active tDCS improved mental skills like attention and processing speed. Another study found that a 10-week course of active tDCS significantly reduced symptoms of depression. These findings suggest that adding active tDCS to brain exercises might enhance its effectiveness in treating depression. However, the improvements observed in these studies were small, so participants should maintain realistic expectations.
The other group will receive Cognitive Training combined with sham tDCS. For this group, the benefits primarily come from the brain exercises alone, which have been shown to improve mental skills.12356Who Is on the Research Team?
Sarah M Szymkowicz, PhD
Principal Investigator
Vanderbilt University Medical Center
Are You a Good Fit for This Trial?
This trial is for adults aged 60 and over who have been diagnosed with Major Depressive Disorder, as per DSM-5 criteria. They should be experiencing cognitive complaints and a depression severity of 15+ on the MADRS scale. Participants must speak English fluently and either be on a stable antidepressant regimen for at least six weeks or not taking any antidepressants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either active or sham tDCS combined with daily computerized cognitive remediation over 4 weeks
Follow-up
Participants are monitored for cognitive and psychiatric outcomes post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Training
- tDCS (active stimulation)
- tDCS (sham stimulation)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
American Academy of Neurology
Collaborator